{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:50:48Z","timestamp":1781189448590,"version":"3.54.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"name":"European Commission under the Life Science Health Priority"},{"name":"Framework Program","award":["278348"],"award-info":[{"award-number":["278348"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1093\/jac\/dkw212","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:08:46Z","timestamp":1465430926000},"page":"2883-2889","source":"Crossref","is-referenced-by-count":33,"title":["Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infections"],"prefix":"10.1093","volume":"71","author":[{"given":"Fiona","family":"Fransen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. B.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Meletiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,6,7]]},"reference":[{"key":"2016092200323773000_71.10.2883.1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq298"},{"key":"2016092200323773000_71.10.2883.2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt328"},{"key":"2016092200323773000_71.10.2883.3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv157"},{"key":"2016092200323773000_71.10.2883.4","unstructured":"EUCAST. Nitrofurantoin: Rationale for the EUCAST Clinical Breakpoints, Version 1.0 . 2010. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Rationale_documents\/Nitrofurantoin_rationale_1.0.pdf ."},{"key":"2016092200323773000_71.10.2883.5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"2016092200323773000_71.10.2883.6","doi-asserted-by":"publisher","DOI":"10.1155\/2001\/601743"},{"key":"2016092200323773000_71.10.2883.7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv147"},{"key":"2016092200323773000_71.10.2883.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2011.02.005"},{"key":"2016092200323773000_71.10.2883.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.06.007"},{"key":"2016092200323773000_71.10.2883.10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku494"},{"key":"2016092200323773000_71.10.2883.11","doi-asserted-by":"crossref","unstructured":"Mouton J , Voss A , Arends J et al . Prevalence of ESBL in the Netherlands: the ONE study. In: Abstracts of the Seventeenth European Congress of Clinical Microbiology and Infectious Diseases, Munich, Germany, 2007. Abstract 1732_283. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.","DOI":"10.1016\/S0924-8579(07)70289-3"},{"key":"2016092200323773000_71.10.2883.12","unstructured":"International Organization for Standardization. Clinical Laboratory Testing and In Vitro Diagnostic Test Systems: Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices. Part 1: Reference Method for Testing the In Vitro Activity of Antimicrobial Agents against Rapidly Growing Aerobic Bacteria Involved in Infectious Diseases. ISO 20776-1:2006 ."},{"key":"2016092200323773000_71.10.2883.13","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544020-00005"},{"key":"2016092200323773000_71.10.2883.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80754-5"},{"key":"2016092200323773000_71.10.2883.15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.suppl_A.23"},{"key":"2016092200323773000_71.10.2883.16","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1128\/AEM.65.7.2877-2894.1999","article-title":"Cell surface analysis techniques: what do cell preparation protocols do to cell surface properties?","volume":"65","author":"Pembrey","year":"1999","journal-title":"Appl Environ Microbiol"},{"key":"2016092200323773000_71.10.2883.17","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr170"},{"key":"2016092200323773000_71.10.2883.18","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1955.00250150011001"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/10\/2883\/7076953\/dkw212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T22:20:20Z","timestamp":1600726820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,9,22]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1093\/jac\/dkw212"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw212","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}